FDA to authorize plasma treatment over scientists' objections

The Food and Drug Administration will issue an emergency authorization for blood plasma as a coronavirus treatment, according to three administration officials.

The agency held off on the decision over concerns from government scientists that evidence for the treatment's effectiveness is thin - prompting President Donald Trump to accuse the FDA of slow-walking the therapy to harm his reelection chances.

Trump will announce the emergency authorization during a Sunday evening press conference with HHS Secretary Alex Azar and FDA Commissioner Stephen Hahn.

Add comment

The author will be very pleased to hear feedback about your news.

reload, if the code cannot be seen

Comments 0